4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001140361-22-007763
SVP, GC & Secretary sold 2,577 shares at an average $9.86 ($25,400)
- SVP, GC & Secretary acquired 51,814 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Murugan Amar SVP, GC & Secretary | 2022-03-01 | Grant or award | +51,814 | 139,535 | D | ||
| Murugan Amar SVP, GC & Secretary | 2022-03-01 | Sale | −1,465 | $9.86 | $14,441 | 138,070 | D |
| Murugan Amar SVP, GC & Secretary | 2022-03-01 | Sale | −1,112 | $9.86 | $10,960 | 136,958 | D |
| Derivatives | |||||||
| Murugan Amar SVP, GC & Secretary | 2022-03-01 | Grant or award · Employee Stock Option (Right to Buy) | +97,398 | 97,398 | D | ||
| Open-market sales · 2,577 sh · avg $9.86 · $25,400 | |||||||
Loading xslF345X03/form4.xml…